Tom P. Freeman

MedicinePsychologyPharmacology, Toxicology and PharmaceuticsNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Consortium profile: the methylation, imaging and NeuroDevelopment (MIND) consortium”.

Consortium profile: the methylation, imaging and NeuroDevelopment (MIND) consortium

Molecular Psychiatry(2025)10.1038/s41380-025-03203-w

N/A

0.208DataRank · unranked

3 citations

Rosa H. Mulder, Vilte Baltramonaityte, Alexandra Lahtinen, Fan Qiuyu, Leonardo Melo Rothmann +42 more

Cannabinoids for the treatment of cannabis use disorder: New avenues for reaching and helping youth?

Neuroscience & Biobehavioral Reviews(2021)10.1016/j.neubiorev.2021.11.033

N/A

0DataRank · unranked

14 citations

Birgitte Thylstrup, Emily A. Kenyon, Rachel Lees, Lone Baandrup, Sarah W. Feldstein Ewing +2 more

Assessing the association between global structural brain age and polygenic risk for schizophrenia in early adulthood: A recall-by-genotype study

Cortex(2023)10.1016/j.cortex.2023.11.015

N/A

0DataRank · unranked

8 citations

Vilte Baltramonaityte, Doretta Caramaschi, Laura K. M. Han, T. Lancaster, Stanley Zammit +3 more

Canada's THC unit: Applications for the legal cannabis market

International Journal of Drug Policy(2024)10.1016/j.drugpo.2024.104457

N/A

0DataRank · unranked

6 citations

Robert Gabrys, Tom P. Freeman, David Hammond, Shea Wood

Consortium Profile: The Methylation, Imaging and NeuroDevelopment (MIND) Consortium

medRxiv(2024)10.1101/2024.06.23.24309353

N/A

0DataRank · unranked

2 citations

Rosa H. Mulder, Vilte Baltramonaityte, Alexandra Lahtinen, Fan Qiuyu, Leonardo Melo Rothmann +37 more